Arkolith/Insider Trading/NBIO/Form 4

Holden Lowell Thomas

CFO, DirectorNascent Biotech Inc. (NBIO) · full profile →Form 4 · filed Jul 25, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1K
Net Open-Market Flow
-$1K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2022Sell(S)5K$0.26$1K8.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477932-22-005350) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML